258 related articles for article (PubMed ID: 20429547)
1. Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release.
Chen S; Zhao X; Chen J; Chen J; Kuznetsova L; Wong SS; Ojima I
Bioconjug Chem; 2010 May; 21(5):979-87. PubMed ID: 20429547
[TBL] [Abstract][Full Text] [Related]
2. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugates.
Vineberg JG; Wang T; Zuniga ES; Ojima I
J Med Chem; 2015 Mar; 58(5):2406-16. PubMed ID: 25654690
[TBL] [Abstract][Full Text] [Related]
4. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.
Chen J; Chen S; Zhao X; Kuznetsova LV; Wong SS; Ojima I
J Am Chem Soc; 2008 Dec; 130(49):16778-85. PubMed ID: 19554734
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of a highly-potent and cancer cell selective folate-taxoid conjugate.
Seitz JD; Vineberg JG; Herlihy E; Park B; Melief E; Ojima I
Bioorg Med Chem; 2015 May; 23(9):2187-94. PubMed ID: 25819334
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapy.
Vineberg JG; Zuniga ES; Kamath A; Chen YJ; Seitz JD; Ojima I
J Med Chem; 2014 Jul; 57(13):5777-91. PubMed ID: 24901491
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.
Maiti S; Park N; Han JH; Jeon HM; Lee JH; Bhuniya S; Kang C; Kim JS
J Am Chem Soc; 2013 Mar; 135(11):4567-72. PubMed ID: 23461361
[TBL] [Abstract][Full Text] [Related]
8. GSH Activated Biotin-tagged Near-Infrared Probe for Efficient Cancer Imaging.
Guo R; Huang F; Zhang B; Yan Y; Che J; Jin Y; Zhuang Y; Dong R; Li Y; Tan B; Song R; Hu Y; Dong X; Li X; Lin N
Theranostics; 2019; 9(12):3515-3525. PubMed ID: 31281494
[TBL] [Abstract][Full Text] [Related]
9. Biotin-Tagged Polysaccharide Vesicular Nanocarriers for Receptor-Mediated Anticancer Drug Delivery in Cancer Cells.
Deshpande NU; Jayakannan M
Biomacromolecules; 2018 Aug; 19(8):3572-3585. PubMed ID: 29906389
[TBL] [Abstract][Full Text] [Related]
10. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
12. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB
Luo Q; Gong P; Sun M; Kou L; Ganapathy V; Jing Y; He Z; Sun J
J Control Release; 2016 Dec; 243():370-380. PubMed ID: 27810556
[TBL] [Abstract][Full Text] [Related]
13. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
14. Efficient delivery of streptavidin to mammalian cells: clathrin-mediated endocytosis regulated by a synthetic ligand.
Hussey SL; Peterson BR
J Am Chem Soc; 2002 Jun; 124(22):6265-73. PubMed ID: 12033853
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
16. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
[TBL] [Abstract][Full Text] [Related]
17. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X
Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507
[TBL] [Abstract][Full Text] [Related]
18. Octreotide-Mediated Tumor-Targeted Drug Delivery via a Cleavable Doxorubicin-Peptide Conjugate.
Lelle M; Kaloyanova S; Freidel C; Theodoropoulou M; Musheev M; Niehrs C; Stalla G; Peneva K
Mol Pharm; 2015 Dec; 12(12):4290-300. PubMed ID: 26524088
[TBL] [Abstract][Full Text] [Related]
19. Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells.
Russo A; Pellosi DS; Pagliara V; Milone MR; Pucci B; Caetano W; Hioka N; Budillon A; Ungaro F; Russo G; Quaglia F
Int J Pharm; 2016 Sep; 511(1):127-139. PubMed ID: 27374195
[TBL] [Abstract][Full Text] [Related]
20. C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein p53 into tumor cells.
Fahrer J; Schweitzer B; Fiedler K; Langer T; Gierschik P; Barth H
Bioconjug Chem; 2013 Apr; 24(4):595-603. PubMed ID: 23506195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
